These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
333 related items for PubMed ID: 14985944
21. Analysis of inhibition, reactivation and aging kinetics of highly toxic organophosphorus compounds with human and pig acetylcholinesterase. Aurbek N, Thiermann H, Szinicz L, Eyer P, Worek F. Toxicology; 2006 Jul 05; 224(1-2):91-9. PubMed ID: 16720069 [Abstract] [Full Text] [Related]
27. Reactivating potency of obidoxime, pralidoxime, HI 6 and HLö 7 in human erythrocyte acetylcholinesterase inhibited by highly toxic organophosphorus compounds. Worek F, Widmann R, Knopff O, Szinicz L. Arch Toxicol; 1998 Mar 05; 72(4):237-43. PubMed ID: 9587020 [Abstract] [Full Text] [Related]
28. Reappraisal of indications and limitations of oxime therapy in organophosphate poisoning. Worek F, Bäcker M, Thiermann H, Szinicz L, Mast U, Klimmek R, Eyer P. Hum Exp Toxicol; 1997 Aug 05; 16(8):466-72. PubMed ID: 9292287 [Abstract] [Full Text] [Related]
30. Comparison of the oxime-induced reactivation of erythrocyte and muscle acetylcholinesterase following inhibition by sarin or paraoxon, using a perfusion model for the real-time determination of membrane-bound acetylcholinesterase activity. Eckert S, Eyer P, Herkert N, Bumm R, Weber G, Thiermann H, Worek F. Biochem Pharmacol; 2008 Feb 01; 75(3):698-703. PubMed ID: 17977518 [Abstract] [Full Text] [Related]
31. Mechanism for potent reactivation ability of H oximes analyzed by reactivation kinetic studies with cholinesterases from different species. Luo C, Chambers C, Yang Y, Saxena A. Chem Biol Interact; 2010 Sep 06; 187(1-3):185-90. PubMed ID: 20096273 [Abstract] [Full Text] [Related]
33. A comparison of the efficacy of a bispyridinium oxime--1,4-bis-(2-hydroxyiminomethylpyridinium) butane dibromide and currently used oximes to reactivate sarin, tabun or cyclosarin-inhibited acetylcholinesterase by in vitro methods. Kuca K, Cabal J, Kassa J. Pharmazie; 2004 Oct 06; 59(10):795-8. PubMed ID: 15544060 [Abstract] [Full Text] [Related]
34. Interactions between acetylcholinesterase, toxic organophosphorus compounds and a short series of structurally related non-oxime reactivators: Analysis of reactivation and inhibition kinetics in vitro. Horn G, de Koning MC, van Grol M, Thiermann H, Worek F. Toxicol Lett; 2018 Dec 15; 299():218-225. PubMed ID: 30312685 [Abstract] [Full Text] [Related]
35. Restoration of nerve agent inhibited muscle force production in human intercostal muscle strips with HI 6. Seeger T, Niessen KV, Langer P, Gerhardus J, Worek F, Friess H, Bumm R, Mihaljevic AL, Thiermann H. Toxicol Lett; 2011 Sep 25; 206(1):72-6. PubMed ID: 21803135 [Abstract] [Full Text] [Related]
37. In vitro and in vivo evaluation of pyridinium oximes: mode of interaction with acetylcholinesterase, effect on tabun- and soman-poisoned mice and their cytotoxicity. Calić M, Vrdoljak AL, Radić B, Jelić D, Jun D, Kuca K, Kovarik Z. Toxicology; 2006 Feb 15; 219(1-3):85-96. PubMed ID: 16332406 [Abstract] [Full Text] [Related]
38. Kinetic analysis of interactions between alkylene-linked bis-pyridiniumaldoximes and human acetylcholinesterases inhibited by various organophosphorus compounds. Wille T, Ekström F, Lee JC, Pang YP, Thiermann H, Worek F. Biochem Pharmacol; 2010 Sep 15; 80(6):941-6. PubMed ID: 20510679 [Abstract] [Full Text] [Related]
39. Comparative kinetics of organophosphates and oximes with erythrocyte, muscle and brain acetylcholinesterase. Herkert NM, Freude G, Kunz U, Thiermann H, Worek F. Toxicol Lett; 2012 Mar 07; 209(2):173-8. PubMed ID: 22230262 [Abstract] [Full Text] [Related]
40. [A comparison of the efficacy of the reactivators of acetylcholinesterase inhibited with tabun]. Cabal J, Kuca K, Jun D, Bajgar J, Hrabinová M. Ceska Slov Farm; 2005 Jul 07; 54(4):192-5. PubMed ID: 16124202 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]